RISEUPTOHIV
RISEUPTOHIV
EDUCATION • COMMUNITY • RESOURCES
About Contact
ES HT
Quick Answer

Can I drink alcohol while on HIV medication?

Answered in plain language, anchored to CDC, HIV.gov, and NIH.

Last reviewed:

Health information — Educational information, not medical advice. Talk with your healthcare provider about your care and treatment decisions.
← Home
Share this answer Facebook X WhatsApp Text Email LinkedIn Reddit Threads Bluesky

Alcohol use is not a reason to withhold or skip HIV treatment. That does not mean drinking is safe for everyone taking ART. Alcohol can affect adherence, liver health and other medicines; people with liver disease, including active hepatitis C, should avoid it. Ask your clinician or pharmacist about your full medication list and health history.[1][3]

There is no alcohol ban in HIV treatment

The NIH adult and adolescent antiretroviral guidelines are explicit: "ongoing substance use is not a contraindication to antiretroviral therapy (ART)," people who use substances "can achieve and maintain viral suppression with ART," and "ongoing alcohol use is not a contraindication for a person to receive ART"[1]. Nobody should be denied treatment, or deny themselves treatment, because they drink.

NIH summarizes studies in which 54%–67% of people with HIV reported some alcohol use; in one sample from seven U.S. university-based HIV clinics, 27% screened positive for unhealthy use. These are study estimates, not a current national prevalence count. Screening and nonjudgmental support belong in routine HIV care. NIH says the best screening frequency is uncertain but advises asking about substance use at each clinical visit.[1][4]

Adherence is an important concern

Missed doses are one important concern, alongside direct health risks and possible medication interactions. NIH guidelines report studies showing "both temporal and dose-related relationships between alcohol use and adherence," with ART "more likely to be missed on a given drinking day and the day after drinking," and a stronger association on heavy or binge drinking days[1]. Unhealthy alcohol use has been associated with interruptions across the HIV care continuum: lower ART adherence, loss of durable viral suppression, higher risk of viral rebound, lower retention in care, and increased mortality[1].

Part of the mechanism is a myth people carry with them. NIH names "patient perceptions of adverse interactions between alcohol and ARV drugs" as one driver of skipped doses[1] — people skip a pill because they had a drink, when the guidance is the opposite. The guidelines conclude that adherence counseling "should highlight the benefits of ART use, irrespective of concurrent substance use"[1]. HIV.gov makes the same point in plainer words: alcohol and drug use can cause people to forget doses and appointments, and missing doses lets HIV multiply[2]. If you drank, still take your dose.

Liver health and hepatitis co-infection: where the advice gets firm

Liver disease is one reason to avoid alcohol; pregnancy, interacting medicines and other circumstances can also make drinking unsafe. NIH states that unhealthy alcohol use alone, and in combination with viral hepatitis co-infection, "can hasten liver fibrosis progression in people with HIV," and that "individuals with liver disease, including active HCV infection, should not consume alcohol"[1]. The same section notes that cirrhosis — from alcohol, viral hepatitis, or metabolic dysfunction–associated steatotic liver disease — "can result in altered metabolism of ARV drugs," with dosing adjusted by Child-Pugh classification, and that regimens with low hepatotoxicity and low drug-interaction potential are preferred for people with substance use disorders[1].

Alcohol can be especially harmful with hepatitis B or C or other liver disease. CDC also advises avoiding alcohol during pregnancy, with interacting medicines, when drinking cannot be controlled, and during recovery from alcohol use disorder. HIV care should include support and treatment for unhealthy alcohol use. If you have been drinking heavily for a prolonged period, seek medical help to stop safely: sudden withdrawal can be dangerous.[3][9][2][4][1]

Two interactions people ask about: abacavir and metronidazole

Abacavir. The prescribing information describes a single-dose interaction study in 24 men with HIV. Ethanol increased abacavir exposure by 41% and its half-life by 26%; abacavir did not alter ethanol levels. The label says no clinically significant interaction is expected in men, and that this interaction has not been studied in women. This small, short study does not establish the safety of heavy drinking or of every combination pill. Discuss your own regimen and liver health with your care team.[5]

Metronidazole. U.S. metronidazole tablet labeling on DailyMed says to avoid alcohol and products containing propylene glycol during treatment and for at least three days afterward. CDC’s bacterial-vaginosis guideline reaches a different conclusion about the evidence: it finds no convincing evidence for a disulfiram-like interaction and says alcohol abstention for that interaction is unnecessary. Follow the instructions for your own prescription and ask your prescriber or pharmacist to resolve the difference; do not replace the label with the old 48-hour advice.[8][6]

What "moderate" actually means

A U.S. standard drink contains 14 grams of alcohol: about 12 ounces of 5% beer, 5 ounces of 12% wine, or 1.5 ounces of 40% spirits. Stronger beers and larger pours can contain more than one drink.[7] HIV.gov describes binge drinking as a pattern reaching a blood alcohol concentration of 0.08% or higher, typically four or more drinks for women or five or more for men in about two hours. Its heavy-use definition is more than three drinks on a day or seven in a week for women, or more than four on a day or fourteen in a week for men. These definitions are not personal safety limits.[2]

CDC’s January 2025 page describes moderation as no more than two drinks in a day for men or one for women. It also says even moderate drinking can increase health risks compared with not drinking, and people who do not drink should not start. Those amounts do not override advice to avoid alcohol because of pregnancy, liver disease, interacting medicines or difficulty controlling use. Bring your actual drinking pattern to your appointment so the plan fits your health and treatment.[3]

Related questions

Will one drink make my HIV medicine stop working?

Drinking alcohol is not a reason to withhold ART, but that is not a guarantee that alcohol is safe with your medicines or health conditions. Keep taking ART as prescribed and ask about interactions, liver health and support for reducing alcohol-related harm.[1][3]

Should I skip my dose if I've been drinking?

Do not skip ART just because you drank. NIH recommends supporting continued treatment even when alcohol use continues. If you are vomiting, cannot take your dose, or have a prescription-specific concern, ask your care team or pharmacist what to do.[1][2]

I have hepatitis C. Is alcohol different for me?

Yes. NIH advises people with liver disease, including active hepatitis C, not to drink alcohol. If you have been drinking heavily for a prolonged period, get medical support to stop safely because sudden withdrawal can be dangerous.[1][9]

Will my provider judge me if I'm honest about drinking?

NIH recommends nonjudgmental care, routine screening and access to treatment and support. You deserve a conversation that helps you protect your health and keep taking ART.[1][4]

Wellness
Sleep, movement, mental health, and the everyday habits that support treatment.
Daily Life with HIV
Routines, reminders, and staying on your regimen when life gets busy.
Treatment Hub
How ART works, what the labs mean, and how to talk to your care team.
Undetectable = Untransmittable
The evidence behind U=U and why staying suppressed matters.
Learning Hub
Plain-language explainers on treatment, prevention, and living well.
Last reviewed: September 2026 by the RiseUpToHIV team. Educational content only — not medical advice.

References & Sources

  1. NIH — Substance Use Disorders and HIV (Adult and Adolescent ARV Guidelines). Primary source: alcohol is not a contraindication to ART; adherence, liver, screening, and treatment guidance. ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩
  2. HIV.gov — Alcohol, Substance Use, and HIV. Standard-drink, binge, and heavy-drinking definitions, plus hepatitis and liver-disease cautions. ↩ ↩ ↩ ↩ ↩
  3. CDC — Moderate Alcohol Use. Dietary Guidelines framing and CDC's caution that even moderate drinking carries risk. ↩ ↩ ↩ ↩ ↩
  4. NIH/DHHS — Substance-use screening and treatment in HIV care; optimal screening frequency is uncertain, but asking at each visit is advised. Source. ↩↩ ↩
  5. Abacavir prescribing information — Single-dose ethanol interaction in 24 men with HIV: exposure increased 41%; no effect on ethanol pharmacokinetics; not studied in women. Source. ↩↩↩
  6. DailyMed — metronidazole oral tablets: prescribing information. The label advises avoiding alcohol and propylene glycol during treatment and for at least three days afterward. ↩ ↩
  7. NIAAA — Standard drinks: 14 grams of alcohol; beverage strength and serving size matter. Source. Checked September 21, 2026. ↩
  8. CDC STI Treatment Guidelines — Bacterial vaginosis; assessment of the evidence for metronidazole and alcohol differs from product labeling. Source. Checked September 21, 2026. ↩
  9. NIAAA — Alcohol use disorder and medically supported withdrawal; suddenly stopping prolonged heavy use can be life-threatening. Source. Checked September 21, 2026. ↩ ↩

Community publications like POZ, Positively Aware, and TheBody inform framing and lived-experience context on RiseUpToHIV. Every clinical, epidemiological, or public-health claim above is anchored to a primary source.

Search RiseUpToHIV